Mapping large numbers of results may take a few moments.
|Company Beam Therapeutics||Activity: Production and Manufacturing||Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site.||Location Durham|
|Company BioMedomics Inc.||Activity: Research and Development||Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology.||Location Morrisville|
|Company Cellectis||Activity: Production and Manufacturing||Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products.||Location Raleigh|
|Company Dova Pharmaceuticals Inc.||Activity: Research and Development||Company Description Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi), develops treatments for orphan diseases. Its lead compound is a treatment for thrombocytopenia in patients with chronic liver disease.||Location Durham|
|Company HemoSonics LLC||Activity: Research and Development||Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care.||Location Durham|